Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 638 results for "kiran mazumdar shaw"

Biocon Q1 net rises 35% to Rs167 crore
Livemint.com

Strong biologics performance boosted Q1: Biocon CMD Kiran Shaw

The most important news that everyone will be tracking is when we submit dossiers in Europe and US for insulin Glargine and that as we have indicated will happen this fiscal, says Kiran Mazumdar Shaw Money Control, 6 days ago
Biocon Q1 net rises 35% to Rs167 crore Livemint.com, 6 days ago
[x]  

77 images for kiran mazumdar shaw

The Hindu, 5 days ago
livemint.com, 6 days ago
Deccan Chronicle, 1 month ago
Hindu Business Line, 1 month ago
Oneindia, 6 days ago
Firstpost.com, 1 month ago
Business Standard, 1 month ago
Business Standard, 1 month ago
Indiatimes, 1 month ago
News18.com, 1 month ago

‘Entrepreneurship is all about ideas’

Kiran Mazumdar-Shaw shares her experiences Bengaluru, July 17: To me, entrepreneurship is really about taking ideas to the market, shaping that idea, validating that idea and commercialising that idea, said Kiran Mazumdar-Shaw, Chairperson and Managing ...
 Business Line1 week ago
Business Standard

PTI - LDALL RAJAN 3 LAST

LDALL RAJAN 3 LAST Contributed by NAMPA / PTI. Biocon chief Kiran Mazumdar Shaw said, "I know many voices in corporate India who are disappointed. Today we are in a very complex economic environment globally, a strong understanding of global ...
 Namibia Press Agency1 month ago When Biocon chairman Kiran Mazumdar met Malala Yousafzai  Economic Times1 month ago We can be very aggressive when we get into US, EU market with our Biosimilars: Kiran Mazumdar Shaw  Smart Investor1 month ago We can be very aggressive in US, EU with biosimilars: Kiran Mazumdar-Shaw  Business Standard1 month ago
[x]  
News18.com

Subramanian Swamy Has No Credibility Globally: Kiran Mazumdar-Shaw

, 7:58 pm After PM's public dressing down to BJP MP Subramanian Swamy, India INC is one sector, which is rejoicing, Bhupendra Chaubey spoke to Chairman of Biocon, Kiran Majumdar Shaw. Bhupendra Chaubey
 News18.com1 month ago After annoying BJP, Swamy promises fewer tweets... for now  MSN News US3 weeks ago Attack on Rajan is BJP's last refuge of patriotism  MSN News US4 weeks ago After PM's snub, Swamy takes refuge in Bhagavad Gita  MSN News US4 weeks ago
[x]  
Deccan Chronicle

Opened up Pandora's box: Kiran Mazumdar-Shaw on Brexit

The UK vote to leave the EU has opened up a "Pandora's box of grave uncertainties" and India cannot be in denial that it will be immune to the development, Biocon CMD Kiran Mazumdar-Shaw has said. "It has opened up a Pandora's box of grave ...
 Business Standard1 month ago Brexit opened up "Pandora's box of grave uncertainties": Kiran Mazumdar-Shaw  Economic Times1 month ago Opened up Pandora's box: Biocon CMD, Kiran Mazumdar-Shaw on Brexit  Deccan Chronicle1 month ago PTI - BREXIT-KIRAN(BCM7) - Opened up Pandora's box: Kiran Mazumdar-Shaw on Brexit  Namibia Press Agency1 month ago
[x]  

Efficient IT backbone necessary to deliver full benefit of GST: Kiran Mazumdar Shaw, Biocon

In an interview with , Kiran Mazumdar Shaw , Biocon, shares her views on the GST Bill. Edited excerpts: ET Now: Do you think now there is a serious possibility that finally the seven-year deadlock on GST would be broken? Kiran Mazumdar Shaw: Well, ...
 Economic Times1 month ago
First Post.com

SBI's Arundhati Bhattacharya in Forbes most powerful people's list

While Ms Bhattacharya has been ranked 25th, others are Chanda Kochhar of ICICI Bank (40th), Kiran Mazumdar-Shaw of Biocon (77th), and Shobhana Bhartia of HT Media, which publishes the Hindustan Times (93rd) The post SBI’s Arundhati Bhattacharya in ...
 First Post.com1 month ago SBI, ICICI Bank chiefs among 4 Indians in Forbes new list  Livemint.com1 month ago Arundhati Bhattacharya, Chanda Kochhar on Forbes' 100 most-powerful women list  DNA1 month ago 4 Indians make it to Forbes' 100 most powerful women list  MSN News US1 month ago
[x]  
International Business Times India

Mylan, Biocon report efficacy of cancer drug

Kiran Mazumdar Shaw Global pharma major Mylan Inc., and Biocon have confirmed the efficacy and safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed by the firms, in comparison to Roche's branded Herceptin used for treatment of ...
 The Hindu1 month ago Biocon, Mylan get EMA review for Neulasta biosimilar  FiercePharma6 days ago Mylan, Biocon upbeat on trial data involving breast cancer drug  Hindu Business Line1 month ago Biocon says four drugs to give 'early mover' advantage in $30-billion market; shares hit 52-week high on BSE  International Business Times India1 month ago
[x]  

Kiran Mazumdar Shaw joins list of billionaires to give their wealth philanthropic causes

BENGALURU: Biocon chief Kiran Mazumdar Shaw has joined a growing list of billionaires from India or of Indian origin who have committed to give the majority of their wealth to philanthropic causes. Shaw is among 17 billionaires to have just signed ...
 Economic Times1 month ago

How Kiran Mazumdar-Shaw broke the glass ceiling witn Biocon (Book Review)

itle: Myth Breaker: Kiran Mazumdar-Shaw & the Story of Indian Biotech; Author: Seema Singh; Publisher: Collins Business; Pages: 324; Price: Rs.599 Start-ups may have become a familiar term in India in the past decade, but this lady dared to delve into such a ...
 Business Standard2 months ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - kiran mazumdar shaw
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less